Below is Validea's guru fundamental report for CLOROX CO (CLX). Of the 22 guru strategies we follow, CLX rates highest using our P/B Growth Investor model based on the published strategy of Partha ...

Barclays analyst Lauren Lieberman maintained a Sell rating on Clorox (CLX – Research Report) today and set a price target of $137.00. The company’s shares closed yesterday at $158.05.

In a report released yesterday, Christopher Carey from Wells Fargo maintained a Sell rating on Clorox (CLX – Research Report), with a price target of $155.00. The company’s shares closed ...

Linda Rendle, Chief Executive Officer at Clorox CLX, disclosed an insider purchase on October 8, based on a new SEC filing. What Happened: In a significant move reported in a Form 4 filing with ...

Membranes were washed 3 x 15 mins in TBS-T, incubated with secondary antibody for 1 hr at RT, washed, and imaged using Odyssey CLx (LI-COR). Antibodies: Histone H3 (Abcam, ab1791, 1:1000); Histone H4 ...

Although Oxford PV prefers to keep the details of their technology classified, there have been decades of research on pure perovskite PV cells as well as tandem perovskite-silicon versions.

Jim Cramer says he doesn't see the economy falling into stagflation. He thinks we just got overheated coming out of the pandemic and now need time to cool off.

The biological properties of pancreatic cancer stem cells (PCSCs) remain incompletely defined and the central regulators are unknown. By bioinformatic analysis of a human PCSC-enriched gene signature, ...